勘误：拉莫三嗪在日本双相情感障碍患者1年观察期内的安全性和有效性评估：上市后监测研究报告[更正]
Erratum: Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum].
出版信息
Neuropsychiatr Dis Treat. 2017 Aug 18;13:2219. doi: 10.2147/NDT.S148233. eCollection 2017.
Abstract
[This corrects the article on p. 1441 in vol. 13, PMID: 28652744.].
摘要
[这纠正了第13卷第1441页上的文章， PMID: 28652744。]
相似文献
1
Erratum: Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum].勘误：拉莫三嗪在日本双相情感障碍患者1年观察期内的安全性和有效性评估：上市后监测研究报告[更正]
Neuropsychiatr Dis Treat. 2017 Aug 18;13:2219. doi: 10.2147/NDT.S148233. eCollection 2017.
2
Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report.日本双相情感障碍患者中拉莫三嗪1年观察期的安全性和有效性评估：上市后监测研究报告
Neuropsychiatr Dis Treat. 2017 Jun 6;13:1441-1448. doi: 10.2147/NDT.S136997. eCollection 2017.
3
Corrigendum.勘误
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
4
Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].勘误：茚达特罗/格隆溴铵在日本慢性阻塞性肺疾病患者中的疗效和安全性：SHINE研究的亚组分析[勘误]
Int J Chron Obstruct Pulmon Dis. 2017 Jan 10;12:231. doi: 10.2147/COPD.S127610. eCollection 2017.
5
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Clin Ophthalmol. 2015 Mar 9;9:453. doi: 10.2147/OPTH.S81448. eCollection 2015.
6
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Clin Ophthalmol. 2015 Jul 22;9:1365. doi: 10.2147/OPTH.S91388. eCollection 2015.
7
Erratum: Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia [Corrigendum].勘误：日本心房颤动患者的合并症负担：消化不良病例研究[勘误]
Clin Exp Gastroenterol. 2013 Sep 23;6:193. doi: 10.2147/CEG.S52344. eCollection 2013.
8
Erratum: Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum].勘误：埃克替尼治疗肺腺癌脑转移患者的疗效和安全性[更正]
Onco Targets Ther. 2017 Mar 21;10:1709. doi: 10.2147/OTT.S135456. eCollection 2017.
9
Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].勘误：艾日布林治疗转移性乳腺癌：安全性和疗效最新进展[勘误]
Int J Womens Health. 2015 Apr 16;7:403. doi: 10.2147/IJWH.S85889. eCollection 2015.
10
Erratum: Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum].勘误：噻托溴铵/奥达特罗与噻托溴铵治疗日本慢性阻塞性肺疾病患者的疗效比较：DYNAGITO研究结果[勘误]
Int J Chron Obstruct Pulmon Dis. 2018 Oct 30;13:3587. doi: 10.2147/COPD.S191099. eCollection 2018.
Zotero 插件